Publications by authors named "Nikhil Parimi"
There is a paucity of data regarding the impact of liver fibrosis on patients with stage D heart failure (HF). We conducted a retrospective study (January 1, 2017 to December 12, 2020) in patients with stage D HF who underwent liver biopsy as part of their advanced HF therapy evaluation. Baseline characteristics and 1-year outcomes were compared between no- or mild-to-moderate-fibrosis (grade 0 to 2) and advanced-fibrosis (grade 3 to 4) groups.
View Article and Find Full Text PDFArticle Synopsis
- This study examined outcomes in advanced heart failure patients on palliative treatments with milrinone or dobutamine, focusing on patients who aren't candidates for major heart procedures.
- A total of 248 patients were analyzed, revealing a 1-year mortality rate of 70%, with the dobutamine group experiencing significantly higher mortality (84% vs. 58%).
- The findings suggest that while both treatments are associated with high mortality, milrinone may lead to better survival rates, likely due to improved adherence to recommended medical therapies like beta-blockers.